User profiles for R. Gray.

Robert M Gray

- Verified email at stanford.edu - Cited by 60133

Robert Gray

- Verified email at jimmy.harvard.edu - Cited by 52363

Rob Gray

- Verified email at st-andrews.ac.uk - Cited by 50406

Corporate social and environmental reporting: a review of the literature and a longitudinal study of UK disclosure

R Gray, R Kouhy, S Lavers - Accounting, auditing & accountability …, 1995 - emerald.com
Takes as its departure point the criticism of Guthrie and Parker by Arnold and the Tinker et al.
critique of Gray et al. Following an extensive review of the corporate social reporting …

Systematic review of levodopa dose equivalency reporting in Parkinson's disease

…, R Stowe, S Patel, C Rick, R Gray… - Movement …, 2010 - Wiley Online Library
… There were no reports of LED for the commercial jejunal L-dopa infusion (Duodopa R ), so
we have accepted the manufacturer's own LED of 90 mg being equivalent to 100 mg of oral L-…

Toeplitz and circulant matrices: A review

RM Gray - Foundations and Trends® in Communications and …, 2006 - nowpublishers.com
… The preferred citation for this publication is RM Gray, Toeplitz and Circulant Matrices: A …
R … [11] RM Gray, “On Unbounded Toeplitz Matrices and Nonstationary Time Series with an …

[BOOK][B] Entropy and information theory

RM Gray - 2011 - books.google.com
… a development along the lines of Gersho and Gray [50] of the basic properties of optimal …
of sliding-block codes as developed by Mao, Gray, and Linder [117]. This material adds to the …

[HTML][HTML] Paclitaxel–carboplatin alone or with bevacizumab for non–small-cell lung cancer

A Sandler, R Gray, MC Perry, J Brahmer… - … England Journal of …, 2006 - Mass Medical Soc
Background Bevacizumab, a monoclonal antibody against vascular endothelial growth factor,
has been shown to benefit patients with a variety of cancers. Methods Between July 2001 …

A proportional hazards model for the subdistribution of a competing risk

JP Fine, RJ Gray - Journal of the American statistical association, 1999 - Taylor & Francis
… This study compared 2 years of tamoxifen therapy to placebo in elderly r> age 65) breast
cancer patients with positive axillary nodes. For particular groups of patients, direct information …

Randomised trial of prophylactic daily aspirin in British male doctors

R Peto, R Gray, R Collins, K Wheatley… - Br Med J (Clin Res …, 1988 - bmj.com
A six year randomised trial was conducted among 5139 apparently healthy male doctors to
see whether 500 mg aspirin daily would reduce the incidence of and mortality from stroke, …

[HTML][HTML] Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient …

…, M Ewertz, R Gray, G Mannu, R Peto… - Database of Abstracts …, 2014 - ncbi.nlm.nih.gov
This review found that after mastectomy and axillary dissection, radiotherapy reduced both
recurrence and breast cancer mortality in women with one to three positive lymph nodes, …

Mortality in relation to smoking: 40 years' observations on male British doctors

R Doll, R Peto, K Wheatley, R Gray, I Sutherland - Bmj, 1994 - bmj.com
Objective: To assess the hazards associated with long term use of tobacco. Design: Prospective
study of mortality in relation to smoking habits assessed in 1951 and again from20time …

The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand

…, W Daniel, R Gray, R Greenwald… - … : Official Journal of …, 1990 - Wiley Online Library
Clinical criteria for the classification of symptomatic idiopathic (primary) osteoarthritis (OA) of
the hands were developed from data collected in a multi‐center study. Patients with OA …